Medidata and PPD Partner to Offer New Approach to Risk-Based Monitoring

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, and CRO Pharmaceutical Product Development (PPD), announced they are expanding their partnership around risk-based monitoring. This effort combines processes to increase data sampling and tracking of source document verification (SDV) through Medidata TSDV (targeted source document verification) with site health assessments and risk evaluation through PPD’s adaptive and intelligent monitoring. This new endeavor will afford clinical research associates increased scrutiny of targeted endpoints that pose the greatest areas of risk in studies. Through this new arrangement, the companies will track specific SDV requirements and compliance directly within EDC systems and will have greater opportunity to focus remote monitoring on targeted criticaldata points.

Read the full release here.